ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag academia drug development policy mri scanning

How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Week in Review: June 16–20
Tracy Vence | Jun 20, 2014 | 2 min read
Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors
National AIDS Task Force Expected To Accelerate Drug Development
Franklin Hoke | Feb 6, 1994 | 8 min read
Bench scientists will play a major role in an ambitious effort to streamline the campaign against HIV The soon-to-be-appointed National Task Force on AIDS Drug Development may have a strong, positive impact on the research and development of antiviral therapies to counter HIV infection, say industry and academic scientists, government officials organizing the task force, and members of the AIDS-affected community. Key to the task
Dealing with Unethical or Illegal Conduct in Higher Education
Anna Azvolinsky | Nov 1, 2017 | 8 min read
Investigations into cases of wrongdoing by professors are increasingly in the public eye. But are colleges and universities doing enough to deal with the problem?
New MRIs on the Horizon
A. J. S. Rayl | Mar 19, 2000 | 7 min read
Courtesy of National Heart, Lung, and Blood InstituteMRI scans of the heart: upper left, torso with heart; upper right, cross section at aortic valve; lower left, lateral view of heart, pulmonic valve, and descending aorta; lower right, four-chamber view In the not too distant future, emergency rooms may well take on the aura of Star Trek's hospital bay. New, state-of-the-art magnetic resonance imaging (MRI) machines offer fast, efficient, and highly detailed data, allowing physicians to make im
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Recent Trials for Fragile X Syndrome Offer Hope
Randi Hagerman | Sep 1, 2019 | 10+ min read
Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.
My Mighty Mouse
Megan Scudellari | Apr 1, 2015 | 10+ min read
Personal drug regimens based on xenograft mice harboring a single patient’s tumor still need to prove their true utility in medicine.
Brain Imaging Struggles for Psychiatric Respect
Douglas Steinberg(dsteinberg@the-scientist.com) | Dec 5, 2004 | 8 min read
Psychiatrists can draw upon long clinical experience with adult patients to surmise why antidepressant medications foster suicidal thoughts and behavior in some children, as the US Food and Drug Administration warned this fall.

Run a Search

ADVERTISEMENT